PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 16 filers reported holding PHIO PHARMACEUTICALS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $558 | -44.2% | 1,500 | -0.1% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,502 | +0.1% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 1,500 | -0.5% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 1,507 | +0.4% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 1,501 | +0.1% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | – | 1,500 | +1644.2% | 0.00% | – |
| Q1 2020 | $0 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 35,929 | $77,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 21,278 | $46,000 | 0.01% |
| UBS Group AG | 566 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 33 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HSBC HOLDINGS PLC | 11,337 | $24,000 | 0.00% |
| BlackRock Inc. | 19 | $0 | 0.00% |
| Citadel Advisors | 12,178 | $26,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 581 | $1,000 | 0.00% |